FDA NDC Directory · JSON-LD · Markdown

Rivastigmine Tartrate

NDC 71209-014 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerCadila Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA203844
Dosage form / routeCAPSULE · ORAL
Active ingredientsRIVASTIGMINE TARTRATE (4.5 mg/1)
Marketing started20140211
Package count2

External sources

Source: openFDA. Public-domain (CC0).